XML 46 R42.htm IDEA: XBRL DOCUMENT v2.4.1.9
STOCK COMPENSATION PLANS (Tables)
3 Months Ended
Mar. 31, 2015
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Unrecognized Share-Based Compensation Expense
The following table presents unrecognized share-based compensation expense as of March 31, 2015: 
 
Unrecognized
Expense
 
Average
Expected
Recognition
Period
 
($ in thousands)
Stock option awards
$
998

 
2.9 years
Restricted stock awards and restricted stock units
9,546

 
3.6 years
Total
$
10,544

 
3.5 years
Option Activity
The following table represents stock option activity as of and for the three months ended March 31, 2015: 
 
Number of
Shares
 
Weighted-
Average
Exercise
Price per
Share
 
Weighted-
Average
Remaining
Contract
Term
 
Aggregated
Intrinsic
Value
(In thousands) 
Outstanding at beginning of period
879,070

 
$
12.67

 
7.3 years
 
$
32

Granted

 
$

 
0.0 years
 
$

Exercised

 
$

 
0.0 years
 
$

Forfeited
(50,540
)
 
$
11.90

 
5.6 years
 
$

Outstanding at end of period
828,530

 
$
12.72

 
7.4 years
 
$
229

Exercisable at end of period
496,016

 
$
11.85

 
7.9 years
 
$
229

Nonvested Share
The following table represents changes in unvested stock options and related information as of and for the three months ended March 31, 2015: 
 
Number
of Shares
 
Weighted-
Average
Exercise
Price per
Share
Outstanding at beginning of period
552,672

 
$
12.74

Granted

 
$

Vested

 
$

Forfeited

 
$

Outstanding at end of period
552,672

 
$
12.74

Restricted Stock and Restricted Stock Units Activity
The following table represents unvested restricted stock awards and restricted stock units activity as of and for the three months ended March 31, 2015: 
 
Number of
Shares
 
Weighted-
Average
Price per
Share
Outstanding at beginning of period
1,287,302

 
$
12.53

Granted
80,670

 
$
10.93

Vested
(22,419
)
 
$
11.06

Forfeited
(28,669
)
 
$
12.22

Outstanding at end of period
1,316,884

 
$
12.46

Summary of all Outstanding SARs
The following table represents a summary of all outstanding SARs (Initial SAR and Additional SARs, together the SARs): 
 
Initial SAR
 
Additional
SAR I
(1)
 
Additional
SAR II
(2)
 
Additional
SAR III
(3)
 
Additional
SAR IV
(4)
 
Additional
SAR V
(5)
 
Additional
SAR VI
(6)
 
Additional
SAR VII
 (7)
Grant Date
8/21/2012

 
6/21/2013

 
7/1/2013

 
7/2/2013

 
12/10/2013

 
5/21/2014

 
5/21/2014

 
11/7/2014

Number of shares
500,000

 
150,933

 
88,366

 
15,275

 
70,877

 
252,023

 
280,110

 
216,334

Base price per share
$
12.12

 
$
13.06

 
$
13.60

 
$
13.55

 
$
12.83

 
$
10.09

 
$
10.09

 
$
11.62

Grant date fair value per share
$
2.77

 
$
2.38

 
$
2.17

 
$
2.19

 
$
2.47

 
$
1.65

 
$
2.22

 
$
1.84

 
(1)
Issued due to the Company’s common stock issuance for an underwritten public offering completed on June 21, 2013.
(2)
Issued due to the Company’s common stock issuance in connection with the PBOC acquisition completed on July 1, 2013.
(3)
Issued due to the Company’s common stock issuance for the exercise of over-allotment option granted to the underwriters of the Company’s public common stock offering initially completed on June 21, 2013.
(4)
Issued due to the Company’s common stock issuance in a private placement completed on December 10, 2013.
(5)
Issued due to the Company’s common stock issuance for an underwritten public offering completed on May 21, 2014.
(6)
The Additional SAR VI originally related to 300,219 shares of common stock with a scheduled vesting of May 21, 2017, as described above. As a result of the settlements of portions of the Purchase Contacts, the Additional SAR VI accelerated in vesting with respect to 143,849 shares and 20,109 shares were forfeited as of March 31, 2015. A portion of Additional SAR VI that has accelerated in vesting has the same terms and conditions as the Initial SAR.
(7)
Issued due to the Company's common stock issuance for a private placement completed on November 7, 2014.